₹1,818.80
+₹110.00 (+6.44%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹28,256 Cr
P/E
98.05
ROE
19.14%
ROCE
22.56%
About Rubicon Research Ltd
Rubicon Research are a pharmaceutical formulations company, driven by innovation through focused research and development, with an increasing portfolio of specialty products and drug-device combination products targeting regulated markets and in particular the United States.(Source : Prospectus Page No: 249)
Founded
1999
CEO
CHANGAVALLI VENKAT
Employees
1,141
HQ
Thane (West), Maharashtra
About Rubicon Research Ltd
Rubicon Research are a pharmaceutical formulations company, driven by innovation through focused research and development, with an increasing portfolio of specialty products and drug-device combination products targeting regulated markets and in particular the United States.(Source : Prospectus Page No: 249)
Founded:1999
CEO:CHANGAVALLI VENKAT
Employees:1,141
HQ:Thane (West), Maharashtra
Finished Products
1Sales
₹1,908.05Cr2Export benefits
₹10.09Cr3Royalty Income
₹9.60CrRaw Materials
1Cost of materials Consumed
₹319.22CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,829
52W Low
₹571
Volume742.78K
Avg VolumeN/A
BetaN/A
Dividend Yield0.09%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
98.05x
Valuation
P/B Ratio
21.92x
Valuation
EPS
₹17.41
Valuation
Dividend Yield
0.09%
Valuation
ROE
19.14%
Profitability
ROCE
22.56%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
1.3%
International
98.7%
USA97.4%
Others1.3%
India1.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.24x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
27.1%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.